Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 12954639)

Published in J Biol Chem on September 03, 2003

Authors

Maddalena Illario1, Anna Lina Cavallo, K Ulrich Bayer, Tiziana Di Matola, Gianfranco Fenzi, Guido Rossi, Mario Vitale

Author Affiliations

1: Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università Federico II, Napoli, 80131 Italy.

Articles citing this

Dual mechanism of a natural CaMKII inhibitor. Mol Biol Cell (2007) 1.86

CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage. J Neurosci (2010) 1.49

Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. J Biol Chem (2010) 1.18

CaMKII in cerebral ischemia. Acta Pharmacol Sin (2011) 1.04

Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration. PLoS One (2014) 1.03

Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience (2006) 1.01

A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization. J Biol Chem (2008) 1.01

Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth. Can J Physiol Pharmacol (2008) 0.99

The multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9. Am J Physiol Heart Circ Physiol (2012) 0.94

Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology (2010) 0.93

Acute insulin signaling in pancreatic beta-cells is mediated by multiple Raf-1 dependent pathways. Endocrinology (2010) 0.93

Prenatal ethanol exposure persistently impairs NMDA receptor-dependent activation of extracellular signal-regulated kinase in the mouse dentate gyrus. J Neurochem (2009) 0.89

Activation of cytosolic phospholipase A2 in dorsal root ganglion neurons by Ca2+/calmodulin-dependent protein kinase II after peripheral nerve injury. Mol Pain (2009) 0.88

Proliferation of human lens epithelial cells (HLE-B3) is inhibited by blocking of voltage-gated calcium channels. Pflugers Arch (2008) 0.85

Improving a natural CaMKII inhibitor by random and rational design. PLoS One (2011) 0.83

Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy. PLoS One (2015) 0.83

Calmodulin and CaMKII modulate ENaC activity by regulating the association of MARCKS and the cytoskeleton with the apical membrane. Am J Physiol Renal Physiol (2015) 0.83

Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cells. Mol Cell Endocrinol (2011) 0.80

CD25 and CD69 induction by α4β1 outside-in signalling requires TCR early signalling complex proteins. Biochem J (2013) 0.78

Sisters Acts: Converging Signaling Between CaMKII and CaMKIV, Two Members of the Same Family. Transl Med UniSa (2012) 0.77

Transient domoic acid excitotoxicity increases BDNF expression and activates both MEK- and PKA-dependent neurogenesis in organotypic hippocampal slices. BMC Neurosci (2013) 0.77

The characteristics of Bax inhibitor-1 and its related diseases. Curr Mol Med (2014) 0.76

Calcium and Superoxide-Mediated Pathways Converge to Induce Nitric Oxide-Dependent Apoptosis in Mycobacterium fortuitum-Infected Fish Macrophages. PLoS One (2016) 0.75

PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells. PLoS One (2014) 0.75

The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth. Oncotarget (2017) 0.75

Stochastic Induction of Long-Term Potentiation and Long-Term Depression. Sci Rep (2016) 0.75

Synergistic effect of ascorbic acid and collagen addition on the increase in type 2 collagen accumulation in cartilage-like MSC sheet. Cytotechnology (2015) 0.75

Retinoschisin is linked to retinal Na/K-ATPase signaling and localization. Mol Biol Cell (2017) 0.75

Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma. Oncotarget (2017) 0.75

Ranolazine promotes muscle differentiation and reduces oxidative stress in C2C12 skeletal muscle cells. Endocrine (2016) 0.75

Glutamine up-regulates MAPK phosphatase-1 induction via activation of Ca(2+)→ ERK cascade pathway. Biochem Biophys Rep (2016) 0.75

Articles by these authors

CaMKII regulation in information processing and storage. Trends Neurosci (2012) 1.96

Dual mechanism of a natural CaMKII inhibitor. Mol Biol Cell (2007) 1.86

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood (2004) 1.83

Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. J Neurosci (2011) 1.70

Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A (2007) 1.54

Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II. Cell Cycle (2009) 1.53

CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage. J Neurosci (2010) 1.49

Radioiodide induces apoptosis in human thyroid tissue in culture. Endocrine (2013) 1.39

CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing. Mol Biol Cell (2006) 1.39

Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. Blood (2007) 1.37

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab (2011) 1.35

The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest (2010) 1.35

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab (2012) 1.30

CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/calmodulin. J Biol Chem (2010) 1.28

Selective translocation of Ca2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses. Proc Natl Acad Sci U S A (2010) 1.24

Acute presentation of spinal epidural cavernous angiomas: case report. Neurosurgery (2007) 1.24

Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. Clin Endocrinol (Oxf) (2013) 1.22

The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem (2002) 1.21

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) (2007) 1.21

Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab (2006) 1.21

Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res (2005) 1.21

Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. J Biol Chem (2010) 1.18

Fine-needle cytology of Hürthle cell tumors and morphometry. Cancer Cytopathol (2014) 1.18

Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost (2005) 1.16

Nucleotides and phosphorylation bi-directionally modulate Ca2+/calmodulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B. J Biol Chem (2011) 1.13

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate (2006) 1.12

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg (2013) 1.10

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol (2011) 1.10

In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res (2006) 1.04

Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther (2007) 1.04

CaMKII in cerebral ischemia. Acta Pharmacol Sin (2011) 1.04

β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology (2012) 1.04

The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Mol Endocrinol (2003) 1.02

Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J Immunol (2004) 1.01

Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. J Clin Endocrinol Metab (2005) 1.00

A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study. Ann Hematol (2011) 1.00

High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab (2011) 1.00

Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients. Eur J Haematol (2009) 0.99

Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. Endocr J (2010) 0.98

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol (2006) 0.98

Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Thyroid (2013) 0.97

Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles. Mol Biol Cell (2012) 0.96

A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid (2008) 0.94

Camkii-mediated phosphorylation regulates distributions of Syngap-α1 and -α2 at the postsynaptic density. PLoS One (2013) 0.94

Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. Thyroid (2013) 0.93

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer (2007) 0.93

An unusual case of primary choriocarcinoma of the lung. BMC Surg (2013) 0.93

Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J Neurosci (2013) 0.92

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. J Clin Endocrinol Metab (2003) 0.92

Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis. BMC Surg (2013) 0.91

Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cell Signal (2009) 0.91

Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients. BMC Surg (2013) 0.91

Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells. Mol Cell Biol (2004) 0.90

Pulmonary sequestration presented as massive left hemothorax and associated with primary lung sarcoma. BMC Surg (2013) 0.90

The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell Mol Life Sci (2010) 0.90

Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. Cell Cycle (2012) 0.89

Migration of surgical clips through a right lobectomy stump mimicking an asthmatic syndrome. BMC Surg (2013) 0.89

A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity. PLoS One (2012) 0.89

Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells. Endocrinology (2007) 0.88

Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells. Toxicol Sci (2010) 0.88

Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature. BMC Surg (2013) 0.87

BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay. Endocrine (2013) 0.87

BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf) (2013) 0.86

Enzymatic activity of CaMKII is not required for its interaction with the glutamate receptor subunit GluN2B. Mol Pharmacol (2013) 0.86

Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients. BMC Surg (2013) 0.85

The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC. Endocr Relat Cancer (2010) 0.84

[Epidemiology of diabetic foot]. Infez Med (2012) 0.84

Limitations of Chromogranin A in clinical practice. Biomarkers (2012) 0.84

The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood (2006) 0.84

Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol (2005) 0.84

Differential regulation by ATP versus ADP further links CaMKII aggregation to ischemic conditions. FEBS Lett (2009) 0.84